MoneyWorks4Me

Jubilant Pharmova’s arm enters into loan agreement with Standard Chartered Bank

14 Jul 2022 Evaluate

Jubilant Pharmova’s step down subsidiary -- Jubilant Pharma Holdings Inc (JPHI) has entered into loan agreement with Standard Chartered Bank. The agreement is for five year loan facility for repayment of existing term loan and bonds aggregating $350 million and additional tranche of $50 million for future growth capex.

Jubilant Pharmova (formerly Jubilant Life Sciences) is a company engaged in pharmaceuticals, contract research and development services and proprietary novel drugs businesses.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..